Pentosan and Macular Disease - A Causal Association?

Hendrik P.N. Scholl*, Caroline C.W. Klaver

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)223-224
Number of pages2
JournalJAMA Ophthalmology
Issue number3
Early online date27 Jan 2022
Publication statusPublished - Mar 2022

Bibliographical note

Funding Information:
grants from the Swiss National Science Foundation Project (“Developing Novel Outcomes for Clinical Trials in Stargardt Disease Using Structure/Function Relationship and Deep Learning” [310030_201165]), the National Center of Competence in Research Molecular Systems Engineering (“NCCR MSE: Molecular Systems Engineering” [phase II] [51NF40-182895]), the Wellcome Trust PINNACLE study, and the Foundation Fighting Blindness ProgStar study. Dr Klaver reported consulting fees from Bayer and Thea Pharma. No other disclosures were reported.

Cite this